Results 61 to 70 of about 5,258 (134)

Gender-Specific Hippocampal Dysrhythmia and Aberrant Hippocampal and Cortical Excitability in the APPswePS1dE9 Model of Alzheimer’s Disease

Neural Plasticity, 2016
Alzheimer’s disease (AD) is a multifactorial disorder leading to progressive memory loss and eventually death. In this study an APPswePS1dE9 AD mouse model has been analyzed using implantable video-EEG radiotelemetry to perform long-term EEG recordings ...
Anna Papazoglou, Julien Soos, Andreas Lundt, Carola Wormuth, Varun Raj Ginde, Ralf Müller, Christina Henseler, Karl Broich, Kan Xie, Dan Ehninger, Britta Haenisch, Marco Weiergräber   +11 more
doaj   +1 more source

Pharmacological profile of dicaffeoylquinic acids and their role in the treatment of respiratory diseases

Frontiers in Pharmacology
Dicaffeoylquinic acids (DCQAs) are polyphenolic compounds found in various medicinal plants such as Echinacea species and Hedera helix, whose multi-constituent extracts are used worldwide to treat respiratory diseases.
Matthias Hufnagel, André Rademaekers, Anika Weisert, Hanns Häberlein, Sebastian Franken   +4 more
doaj   +1 more source

Clinical evaluation of the efficacy and safety of nasturtium herb and horseradish root versus placebo in the continuous prophylaxis of recurrent uncomplicated cystitis: a double-blind randomised clinical trial

BMC Complementary Medicine and Therapies
Background and objectives This study aimed to demonstrate the efficacy and safety of a herbal combination drug of nasturtium herb and horseradish root in the continuous prophylaxis of recurring uncomplicated cystitis.
Uwe Albrecht, Gregor Schmitz, Ulrich Stefenelli, Nina Kassner, Meinolf Wonnemann, Lukas Schablauer, Niklas Lonnemann, Lisa Felix, Ruth Kirschner-Hermanns   +8 more
doaj   +1 more source

Innovative Arzneimittel: Gesundheits- und Standortfaktor statt Kostenblock

Monitor Versorgungsforschung
Value of Health – Gesundheit ist ein Standortfaktor, kein Kostenfaktor Wer Gesundheit primär als Kostenblock betrachtet, verkennt ihren langfristigen Ertrag für Gesellschaft, Wirtschaft und Staat – ganz zu schweigen vom Nutzen für die Patient:innen ...
Christian Thams
doaj   +1 more source

A case study comparing anonymized and synthetic health insurance claims data for medication safety assessments

npj Digital Medicine
Synthetic data generation is increasingly proposed as an alternative to classical anonymization for sharing health data. We compared concrete applications of both approaches on a small, high-dimensional health claims dataset, assessing their impact on ...
Mehmed Halilovic, Thierry Meurers, Marco Alibone, Marion Ludwig, Paul Tiwald, Nico Sieberg-Riedel, Steven Wolter, Lisa Kühnel, Steffen Hess, Fabian Prasser, Karen Otte   +10 more
doaj   +1 more source

ADHD medicine consumption in Europe after COVID-19: catch-up or trend change?

BMC Psychiatry
Background Although the COVID-19 pandemic and its implications have been associated with mental health services utilization and medication consumption, there is no longitudinal study on the long-term impact on ADHD medication use trends.
Sophie Gimbach, Daniel Vogel, Roland Fried, Stephen V. Faraone, Tobias Banaschewski, Jan Buitelaar, Manfred Döpfner, Richard Ammer   +7 more
doaj   +1 more source

In Vitro Antibacterial and Antifungal Activity of an (Syn.: ) Extract

Natural Product Communications
Objective: To assess the antibacterial and antifungal activity in vitro of a patented Spirulina extract on sensitive and multidrug-resistant bacteria, yeasts, and filamentous fungi commonly causing skin infections. Methods: The antimicrobial activity was
Elisa Pianta, Nils Günnewich, Christian Zimmermann, Patrick Günther, Orlando Petrini, Juan Diaz-Miyar, Cristina Fragoso-Corti   +6 more
doaj   +1 more source

[Exposure inquiries related to preparations containing plant-based ingredients in Germany: analysis of inquiries (2013-2022) at the Joint Poison Information Center in Erfurt]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Wendt S, Linden D, Prasa D, Franke H.
europepmc   +1 more source

[Consequences of late access to specialist care-effect on medication costs in rheumatoid arthritis]. [PDF]

Z Rheumatol
Licker LV, Pardey N, Kreis K, Stahmeyer JT, Zinke S, Meyer-Olson D, Witte T, Hoeper K, Zeidler J.   +8 more
europepmc   +1 more source

[Recording medication errors in Germany-a workshop report]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Vogt B, Kayser C, Köberle U, Kupferschmidt H, Langebrake C, Müller B, Rascher W, Said A, Schwalbe O, Thürmann P.   +9 more
europepmc   +1 more source